Table 3.
Angiographic findings and outcome according to statin use.
| Variable | Study groups | P value | |
|---|---|---|---|
| Statin (N = 386) | Non-statin (N = 521) | ||
| Follow-up time (months) | 44.4 ± 37.2 | 47.1 ± 33.1 | .27 |
| Number of diseased vessel | .05 | ||
| Single vessel disease | 158 (40.9%) | 245 (47.0%) | |
| Dual vessel disease | 140 (36.3%) | 150 (28.8%) | |
| Triple vessel disease | 88 (22.8%) | 126 (24.2%) | |
| Mean of treated vessels | 1.3 ± 0.5 | 1.3 ± 0.5 | .28 |
| Mean of treated lesions | 1.6 ± 0.8 | 1.5 ± 0.8 | .26 |
| SYNTAX score | 12.4 ± 8.0 | 11.4 ± 8.4 | .09 |
| LVEF (%) | 56 ± 14 | 56 ± 13 | .49 |
| Type of intervention | <.01* | ||
| Balloon angioplasty | 74 (19.2%) | 153 (29.4%) | |
| BMS deployment | 166 (43.0%) | 238 (45.7%) | |
| DES deployment | 201 (52.1%) | 200 (38.4%) | |
| MI | .07 | ||
| Yes | 9 (2.3%) | 17 (3.3%) | |
| No | 377 (97.7%) | 504 (96.7%) | |
| CV death | <.01* | ||
| Yes | 9 (2.3%) | 41 (7.9%) | |
| No | 377 (97.7%) | 480 (92.1%) | |
| All-cause death | <.01* | ||
| Yes | 14 (3.6%) | 75 (14.4%) | |
| No | 372 (96.4%) | 446 (85.6%) | |
| Re-PCI | .37 | ||
| Yes | 137 (35.5%) | 170 (32.6%) | |
| No | 249 (64.5%) | 351 (67.4%) | |
BMS = bare-metal stent, CV death = cardiovascular death, DES = drug-eluting stent, DM = diabetes mellitus, HC = hypercholesterolemia, LVEF = left ventricular ejection fraction, MI = myocardial infarction, Re-PCI = repeated percutaneous coronary intervention, SYNTAX score = Synergy Between PCI With Taxus and Cardiac Surgery score.
*
Significant.